Drawing for ASCO

USPTO serial 87724285

ASCO

Reviewed by CopyMark Law Group

Reg. 5664766Status 702Registered
Filing date
Status date
Registration date
Jan 29, 2019
Examiner
MIRANDA, JOHN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ASCO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emilia F. Cannella

Emilia F. Cannella ROPES & GRAY LLPPRUDENTIAL TOWER, 800 BOYLSTON STREETBOSTON, MA 02199-3600United States

Goods and services

ClassDescriptionStatusFirst use
035Advertising services, namely, providing advertising space and promotion services for the medical industry; business management consultancy, advisory, business consulting in regards to quality improvement tools and services, and business information services in the field of oncologyACTIVENov 5, 1964
041Educational services and career resources in the nature of providing educational services, namely, publishing on-line electronic publications and providing classes, on-line classes, seminars, conferences, symposia, and workshops for the exchange and diffusion of information and ideas relating to neoplastic diseases and training in the practice of clinical research and medical care of patients with neoplastic diseases and providing course materials in connection therewithACTIVENov 5, 1964
042Providing medical and scientific research and conducting clinical trials for others in the field of oncologyACTIVENov 5, 1964
044Providing cancer-related medical information for patients and their families via a multi-user global computer information network, or on-line via the internet or a computer network; providing cancer-related medical information for patients and their families; providing medical and patient medical information in the field of clinical oncology via a multi-user global computer information network, or on-line via the internet or a computer network; providing medical and patient medical information in the field of clinical oncology; providing quality improvement tools and services for medical practices in the field of clinical oncology; provision of medical information, advice and consultancy all relating to alleviation, diagnosis, prevention, treatment, quality control and quality improvement in the field of oncologyACTIVENov 5, 1964

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 31, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 30, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 8, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jan 29, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 29, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2018DOCKASSIGNED TO EXAMINER—
Jan 4, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance